VERTEX PHARMACEUTICALS INC / MA Logo

VERTEX PHARMACEUTICALS INC / MA

Develops transformative medicines for serious diseases, specializing in cystic fibrosis.

VRTX | US

Overview

Corporate Details

ISIN(s):
US92532F1003
LEI:
Country:
United States of America
Address:
50 NORTHERN AVENUE, 2210 BOSTON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Vertex Pharmaceuticals is a global biotechnology company that discovers, develops, and commercializes transformative medicines for people with serious diseases. The company is a recognized leader in the treatment of cystic fibrosis (CF), having developed a portfolio of therapies that treat the underlying cause of the disease. Vertex focuses on scientific innovation and invests in research for specialty market diseases with high unmet medical needs, leveraging a deep understanding of causal human biology. Its research and development pipeline extends beyond CF to include other serious conditions such as sickle cell disease, beta-thalassemia, acute pain, and type 1 diabetes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all VERTEX PHARMACEUTICALS INC / MA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for VERTEX PHARMACEUTICALS INC / MA

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for VERTEX PHARMACEUTICALS INC / MA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

DiaMedica Therapeutics Inc. Logo
Developing a novel protein therapy for acute ischemic stroke and preeclampsia.
United States of America
DMAC
Diamyd Medical AB (publ) Logo
Developing precision immunotherapies to preserve insulin in autoimmune diabetes.
Sweden
DMYD
Dianthus Therapeutics, Inc. /DE/ Logo
Developing selective antibody therapies for severe autoimmune diseases.
United States of America
DNTH
Diasorin Logo
Develops immunodiagnostic and molecular diagnostic kits and systems for healthcare and research.
Italy
DIA
Disc Medicine, Inc. Logo
Developing novel therapies for patients with serious hematologic and rare blood disorders.
United States of America
IRON
DONG-A ST CO.,LTD Logo
Develops and distributes ethical drugs, medical devices, and diagnostics for global healthcare.
South Korea
170900
DongKoo Bio & Pharma Co., Ltd. Logo
Pharma leader in dermatology, developing treatments, probiotics, and investing in biotech therapies.
South Korea
006620
DongKook Life Science Co., Ltd. Logo
A pharmaceutical firm specializing in contrast media for diagnostic imaging and medical devices.
South Korea
303810
DongKookPharmaceuticalCo.,Ltd. Logo
Develops, manufactures, and distributes pharmaceuticals and healthcare products globally.
South Korea
086450
DONGSUNG PHARMACEUTICAL CO.,LTD Logo
A Korean firm making pharmaceuticals, cosmetics, and popular hair care products for over 60 years.
South Korea
002210

Talk to a Data Expert

Have a question? We'll get back to you promptly.